Literature DB >> 18775119

Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?

Samar A Nasser1, Zongshan Lai, Shannon O'Connor, Xuefeng Liu, John M Flack.   

Abstract

Recently, clinical trial data showed that rapid attainment of goal blood pressure (BP) reduces the risk for cardiovascular disease (CVD) events. It is unknown whether patient characteristics linked to the magnitude of CVD risk influence the speed of BP control. Time to attain goal systolic BP (SBP) in Kaplan-Meier survival curves was contrasted for strata of baseline characteristics and intensity of hypertension treatment. Survival analyses showed that albuminuria, diabetes, increased body mass index, millimeters of mercury above Joint National Committee (JNC) SBP goal, higher Framingham risk score, older age, depressed estimated glomerular filtration rate, and greater intensity of antihypertensive drug treatment all predicted slower JNC SBP goal attainment (P < 0.015); the intensity of antihypertensive drug therapy when goal BP was attained was also greater in all conditions linked to slow goal attainment. Cox proportional hazards model that included the above patient characteristics revealed all characteristics slowed attainment of JNC SBP goals (P < 0.03). Thus, patient characteristics influence speed of BP control and practitioners should avoid therapeutic inertia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775119     DOI: 10.1007/s11906-008-0074-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  27 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

2.  Overcome clinical inertia to control systolic blood pressure.

Authors:  Patrick J O'Connor
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.

Authors:  Eni C Okonofua; Kit N Simpson; Ammar Jesri; Shakaib U Rehman; Valerie L Durkalski; Brent M Egan
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

5.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

6.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

8.  Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.

Authors:  R Carlini; C I Obialo; M Rothstein
Journal:  Am J Hypertens       Date:  1993-02       Impact factor: 2.689

9.  Detection and control of hypertension in the population: the United States experience.

Authors:  P J Mulrow
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

10.  Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Authors:  Jan A Staessen; Lutgarde Thijisq; Robert Fagard; Hilde Celis; Willem H Birkenhäger; Christopher J Bulpitt; Peter W de Leeuw; Astrid E Fletcher; François Forette; Gastone Leonetti; Patricia McCormack; Choudomir Nachev; Eoin O'Brien; José L Rodicio; Joseph Rosenfeld; Cinzia Sarti; Jaakko Tuomilehto; John Webster; Yair Yodfat; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-04       Impact factor: 4.844

View more
  9 in total

Review 1.  Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Authors:  Carolyn H Still; Keith C Ferdinand; Gbenga Ogedegbe; Jackson T Wright
Journal:  J Am Geriatr Soc       Date:  2015-10       Impact factor: 5.562

2.  Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

Authors:  Phillip D Levy; Robina Josiah Willock; Michael Burla; Aaron Brody; James Mahn; Alexander Marinica; Samar A Nasser; John M Flack
Journal:  J Am Soc Hypertens       Date:  2016-10-28

3.  Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.

Authors:  Michael J Twiner; Alexander L Marinica; Kenneth Kuper; Allen Goodman; James J Mahn; Michael J Burla; Aaron M Brody; Justin A Carroll; Robina Josiah Willock; John M Flack; Samar A Nasser; Phillip D Levy
Journal:  Acad Emerg Med       Date:  2017-01-30       Impact factor: 3.451

4.  Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study.

Authors:  Vicente Gil-Guillén; Domingo Orozco-Beltrán; Emilio Márquez-Contreras; Ramón Durazo-Arvizu; Richard Cooper; Salvador Pita-Fernández; Diego González-Segura; Concepción Carratalá-Munuera; José Luis Martín de Pablo; Vicente Pallarés; Salvador Pertusa-Martínez; Antonio Fernández; Josep Redón
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

5.  Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure.

Authors:  Monica Doménech; Antonio Coca
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

Review 6.  No Time to Waste: in Support of Aggressive and Immediate Management of Hypertension.

Authors:  Marat Fudim; Sreekanth Vemulapalli
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

7.  Current perspectives on combination therapy in the management of hypertension.

Authors:  Samir G Mallat; Houssam S Itani; Bassem Y Tanios
Journal:  Integr Blood Press Control       Date:  2013-06-17

8.  The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease.

Authors:  Sally Hull; Gavin Dreyer; Ellena Badrick; Alistair Chesser; Muhammad Magdi Yaqoob
Journal:  BMC Nephrol       Date:  2011-09-06       Impact factor: 2.388

9.  Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.

Authors:  Chenxi Huang; Sanket S Dhruva; Andreas C Coppi; Frederick Warner; Shu-Xia Li; Haiqun Lin; Khurram Nasir; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2017-11-13       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.